EAM
AMAG

EverPoint Asset Management’s AMAG Pharmaceuticals AMAG Stock Holding History

EverPoint Asset Management’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$4.18M Buy
+120,000
New +$3.59M 0.08% 273

Other funds holding AMAG

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

EverPoint Asset Management's AMAG Position: Q3 2016 in Review

EverPoint Asset Management sold out of AMAG Pharmaceuticals (AMAG) in Q3 2016, closing a stake of 780,000 shares — an estimated $18.7M sold.

EverPoint Asset Management first reported a position in AMAG in Q4 2014 and held it in 5 quarters. The position peaked at $24.9M in Q1 2015. 178 funds tracked by Wall St. Rank hold AMAG as of Q3 2016.

  • EverPoint Asset Management reported no remaining AMAG Pharmaceuticals position as of Q3 2016 after selling out during the quarter.
  • EverPoint Asset Management sold 780,000 AMAG Pharmaceuticals shares in Q3 2016, an estimated $18.7M.
  • EverPoint Asset Management first reported a position in AMAG Pharmaceuticals in Q4 2014 and held it in 5 quarters.
  • EverPoint Asset Management's AMAG Pharmaceuticals position peaked at $24.9M in Q1 2015.
  • 178 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q3 2016.

Based on EverPoint Asset Management's 13F filing for Q3 2016, filed 14 Nov 2016.